arrow
C

Carmen Herranz

institut d'investigacio biomedica de bellvitge (idibell)
H指数:13
被引数:602

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Novel WRN Helicase Inhibitors Selectively Target Microsatellite-Unstable Cancer Cells
2024-04-066
PRE
Novel WRN helicase inhibitors selectively target microsatellite unstable cancer cells
2024-03-220
PRE
Modification of BRCA1-associated breast cancer risk by HMMR overexpression

通过HMMR过表达改变BRCA1-associated乳腺癌风险

2022-04-0725
OAAI
Altered regulation of BRCA1 exon 11 splicing is associated with breast cancer risk in carriers of BRCA1 pathogenic variants

BRCA1外显子11剪接调控的改变与BRCA1致病变异携带者的乳腺癌风险相关

2021-08-3110
OAAI
Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis
2021-08-116
OAAI
Heterogeneity and Cancer-Related Features in Lymphangioleiomyomatosis Cells and Tissue
2021-07-264
OA
Design of phase II, randomized, placebo-controlled study of loratadine associate with rapamycin in patients with lymphangioleiomyomatosis (LAM)
2020-10-280
PRE
AhR controls redox homeostasis and shapes the tumor microenvironment in BRCA1-associated breast cancer

AhR控制BRCA1-associated乳腺癌的氧化还原稳态并塑造肿瘤微环境

2019-02-0789
OAAI
Tumor xenograft modeling identifies an association between TCF4 loss and breast cancer chemoresistance

肿瘤异种移植建模确定TCF4丢失与乳腺癌化疗耐药之间的关联

2018-01-0113
OAAI
Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition
2016-12-1931
OAAI
Study of breast cancer incidence in patients of lymphangioleiomyomatosis
2016-03-079
OAAI